Literature DB >> 28438872

Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases.

Toshiaki Yoshimoto1, Yuji Morine2, Satoru Imura1, Tetsuya Ikemoto1, Syuichi Iwahashi1, Y U Saito1, Sinichiro Yamada1, Daichi Ishikawa1, Hiroki Teraoku1, Masato Yoshikawa1, Jun Higashijima1, Chie Takasu1, Mitsuo Shimada1.   

Abstract

BACKGROUND: Surgical resection is currently considered the only potentially curative option as a treatment strategy of colorectal liver metastases (CRLM). However, the criteria for selection of resectable CRLM are not clear. The aim of this study was to confirm a new prognostic indicator of CRLM after hepatic resection. PATIENTS AND METHODS: One hundred thirty nine patients who underwent initial surgical resection from 1994 to 2015 were investigated retrospectively. Prognostic factors of overall survival including the product of maximum diameter and number of metastases (MDN) were analyzed.
RESULTS: Primary tumor differentiation, vessel invasion, lymph node (LN) metastasis, non-optimally resectable metastases, H score, grade of liver metastases, resection with non-curative intent and MDN were found to be prognostic factors of overall survival (OS). In multivariate analyses of clinicopathological features associated with OS, MDN and non-curative intent were independent prognostic factors. Patients with MDN ≥30 had shown significantly poorer prognosis than patients with MDN <30 in OS and relapse-free survival (RFS).
CONCLUSION: MDN ≥30 is an independent prognostic factor of survival in patients with CRLM and optimal surgical criterion of hepatectomy for CRLM. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Colorectal liver metastases; MDN; prognostic factor

Mesh:

Year:  2017        PMID: 28438872      PMCID: PMC5461454          DOI: 10.21873/invivo.11076

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  25 in total

Review 1.  Pooled analysis of the surgical treatment for colorectal cancer liver metastases.

Authors:  G Veereman; J Robays; L Verleye; R Leroy; C Rolfo; E Van Cutsem; D Bielen; W Ceelen; E Danse; M De Man; P Demetter; P Flamen; A Hendlisz; I Sinapi; D Vanbeckevoort; D Ysebaert; M Peeters
Journal:  Crit Rev Oncol Hematol       Date:  2015-01-14       Impact factor: 6.312

Review 2.  Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.

Authors:  Abdul Saied; Steven C Katz; N Joseph Espat
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

3.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

4.  Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system.

Authors:  S Iwatsuki; I Dvorchik; J R Madariaga; J W Marsh; F Dodson; A C Bonham; D A Geller; T J Gayowski; J J Fung; T E Starzl
Journal:  J Am Coll Surg       Date:  1999-09       Impact factor: 6.113

Review 5.  Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group.

Authors:  Bernard Nordlinger; Eric Van Cutsem; Philippe Rougier; Claus-Henning Köhne; Marc Ychou; Alberto Sobrero; Rene Adam; Dag Arvidsson; Alfredo Carrato; Vassilis Georgoulias; Felice Giuliante; Bengt Glimelius; Markus Golling; Thomas Gruenberger; Josep Tabernero; Harpreet Wasan; Graeme Poston
Journal:  Eur J Cancer       Date:  2007-09-04       Impact factor: 9.162

6.  Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases.

Authors:  A Serrablo; P Paliogiannis; F Pulighe; S Saudi-Moro Moro; V Borrego-Estella; F Attene; F Scognamillo; C Hörndler
Journal:  Eur J Surg Oncol       Date:  2016-02-23       Impact factor: 4.424

Review 7.  Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis.

Authors:  Giovanni Brandi; Stefania De Lorenzo; Margherita Nannini; Stefania Curti; Marta Ottone; Filippo Gustavo Dall'Olio; Maria Aurelia Barbera; Maria Abbondanza Pantaleo; Guido Biasco
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 8.  Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.

Authors:  Emily Khoo; Stephen O'Neill; Ewan Brown; Stephen J Wigmore; Ewen M Harrison
Journal:  HPB (Oxford)       Date:  2016-04-20       Impact factor: 3.647

9.  Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.

Authors:  T Gruenberger; J Bridgewater; I Chau; P García Alfonso; M Rivoire; S Mudan; S Lasserre; F Hermann; D Waterkamp; R Adam
Journal:  Ann Oncol       Date:  2014-12-23       Impact factor: 32.976

10.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Soichiro Ishihara; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2015-03-18       Impact factor: 3.402

View more
  2 in total

1.  Complications associated with iliosacral lymphadenectomy in dogs with metastatic apocrine gland anal sac adenocarcinoma.

Authors:  Yael Huerta; Carlos H De Mello Souza; Laura E Selmic; Alysha McGrath; Owen T Skinner; Katelin V Dark; Marine Traverson; William L Snell; Elizabeth A Maxwell; Judith Bertran; Michelle M M Hasiuk
Journal:  Can Vet J       Date:  2022-09       Impact factor: 1.075

2.  Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.

Authors:  K Tai; S Komatsu; K Sofue; M Kido; M Tanaka; K Kuramitsu; M Awazu; H Gon; D Tsugawa; H Yanagimoto; H Toyama; S Murakami; T Murakami; T Fukumoto
Journal:  BJS Open       Date:  2020-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.